Generic chemoprevention of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Generic chemoprevention of hepatocellular carcinoma

Published:2018-09-17 Issue:1 Volume:1440 Page:23-35
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Athuluri‐Divakar Sai Krishna¹,Hoshida Yujin¹

Affiliation:

1. Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas

Funder

U.S. Department of Defense

Cancer Prevention and Research Institute of Texas

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.13971

Reference155 articles.

1. Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice

2. Epidemiology of Hepatocellular Carcinoma

3. Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review

4. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

5. Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Don’t Judge a Book by Its Cover: The Role of Statins in Liver Cancer;Cancers;2023-10-22

2. Transcriptome and proteome analysis reveals the anti-cancer properties of Hypnea musciformis marine macroalga extract in liver and intestinal cancer cells;Human Genomics;2023-07-31

3. The Role of Metformin as Chemopreventive Strategies for Hepatocellular Carcinoma;Research Journal of Pharmacy and Technology;2023-01-27

4. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma;World Journal of Gastroenterology;2023-01-14

5. Hepatocellular Carcinoma Chemoprevention with Generic Agents;Seminars in Liver Disease;2022-09-14